Can GLP-1 Drugs Like Ozempic Really Change Your Sense of Smell and Taste?

Some GLP-1 users report changes in their taste and smell, according to a new study. Tatsiana Volkava/Getty Images Researchers report that GLP-1 drugs used to treat type 2 diabetes may impair a person’s sense of taste and smell.
Sourcing & attribution. Newseze provides AI-curated summaries, narrative framing, and editorial analysis. The underlying reporting was contributed by Healthline; tap “Open original source” above to read their full reporting and support the contributing newsroom directly.
Newseze's algorithm reads the story and answers your question — calmly, factually, with source attribution. No comments, no flame wars — just answers.
No questions yet. Be the first.
Answers reflect Newseze's editorial framework applied under fair use (17 U.S.C. § 107). Not financial, legal, medical, or tax advice. Hate speech and racial slurs are blocked.
Related stories

Why it mattersResearchers compared intermittent fasting with calorie counting and found that people following fasting protocols thought about food less often. Anchiy/Getty Images A recent study found that people who bounce from one di…
Researchers compared intermittent fasting with calorie counting and found that people following fasting protocols thought about food less often. Anchiy/Getty Im…

Why it mattersNEW YORK, NEW YORK – JUNE 18: Fans cheer for the New York Knicks as a float with Karl-Anthony Towns and teammates pass by during the New York Knicks Championship ticker tape parade and victory rally celebrating win…
NEW YORK, NEW YORK – JUNE 18: Fans cheer for the New York Knicks as a float with Karl-Anthony Towns and teammates pass by during the New York Knicks Champ…

Why it mattersResearchers say that GLP-1 drugs containing tirzepatide (Zepbound, Mounjaro) may lead to greater weight loss. Image Credit: Tatsiana Volkava/Getty Images A meta-analysis found that one type of GLP-1 medication may be mor…
Researchers say that GLP-1 drugs containing tirzepatide (Zepbound, Mounjaro) may lead to greater weight loss. Image Credit: Tatsiana Volkava/Getty Images A meta…

Why it mattersAn estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials announced the launch of a Medicare GLP-1 Bridge pilot program…
An estimated 14 million Medicare Part D recipients could obtain Wegovy, Foundayo, and Zepbound for $50 per month. Johner Images/Getty Images Federal officials a…